Lipid and Lipoprotein Disorders

Current Clinical Solutions - Lipid and Lipoprotein Disorders

Lipids Guidelines Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/76511

Contents of this Issue

Navigation

Page 3 of 27

Diagnosis and Assessment of Disease Basic Lipid/Lipoprotein Physiology ÎLipoproteins can be categorized by their: • Buoyancy (density) • Surface protein content (apolipoproteins B [apoB] and A-I [apoA-I]) • Particle concentration (very low-density lipoprotein particle [VLDL-P], LDL-P, intermediate density lipoprotein particle [IDL-P], high-density lipoprotein particle [HDL-P]) • Cholesterol content (total cholesterol [TC], HDL-C, LDL-C, VLDL-C) • All can be used to assess atherosclerotic risk to varying degrees, but current evidence is that atherogenic particle concentrations (number) are more related to risk and are superior to conventional lipid concentrations as goals of therapy. Table 1. Definitions22 ApoA-I ApoB HDL-C HDL-P hs-CRP IDL-P LDL-C LDL-P LDL size Collective estimate of all of the apolipoprotein A-I containing lipoproteins Collective concentration of all of the apolipoprotein B containing lipoproteins Cholesterol content within all of the HDL particles in a dL of plasma Number of HDL particles in a liter of plasma (μmol/L); This represents all sized HDL particles—large, medium, and small. High sensitivity C-reactive protein – nonspecific inflammatory marker which is a CVD risk factor at levels ≥ 2.0 mg/dL up to 10 mg/dL Number of IDL particles in a liter of plasma (nmol/L) Cholesterol content within all the IDL and LDL particles in a dL of plasma Number of LDL particles in a liter of plasma (expressed in nmol/L). This represents all sized LDL particles, large and small. Diameter of the predominant LDL species Pattern or phenotype A refers to predominantly larger, buoyant LDL particles Pattern or phenotype B refers to predominantly smaller, dense LDL particles Lp(a) Lp(a)-C Lp-PLA2 TC TG VLDL-C VLDL-P 2 Concentration of apo(a) in a dL of plasma Cholesterol content of LDL particles that have apo(a) attached Lipoprotein phospholipase A2 – atheroma specific inflammatory marker Non-HDL-C The cholesterol within all of the apoB particles in a dL of plasma Small LDL-P Number of small and intermediate LDL particles per liter of plasma (nmol/L) Cholesterol content within every lipoprotein in a deciliter of plasma Triacylglycerol concentration within all of the TG-trafficking lipoproteins in a dL of plasma Cholesterol content within all of the VLDL particles in a dL of plasma (note: National Cholesterol Education Program [NCEP] recommends using VLDL-C as your surrogate of remnant-C) Number of VLDL particles in a liter of plasma (nmol/L)

Articles in this issue

Archives of this issue

view archives of Lipid and Lipoprotein Disorders - Current Clinical Solutions - Lipid and Lipoprotein Disorders